• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Catalyst Pharmaceuticals (CPRX)

Common Shares
Sell: $25.72|Buy: $26.50|Change: 0.85 (3.35%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Address

355 Alhambra Circle
Suite 1250
Coral Gables
FL
USA
33134

Telephone

+1 305 4203200

Website

https://www.catalystpharma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Catalyst Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20262027-02-26T08:30:00
Catalyst Pharmaceuticals Inc Fourth Quarter Earnings Results for 20262027-02-25T00:00:00
Catalyst Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20262026-11-06T08:30:00
Catalyst Pharmaceuticals Inc Third Quarter Earnings Results for 20262026-11-05T00:00:00
Catalyst Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20262026-08-07T08:30:00
Catalyst Pharmaceuticals Inc Second Quarter Earnings Results for 20262026-08-06T00:00:00
Catalyst Pharmaceuticals Inc Annual General Meeting for 20252026-05-20T09:00:00
Catalyst Pharmaceuticals Inc First Quarter Earnings Conference Call for 20262026-05-08T08:30:00
Catalyst Pharmaceuticals Inc First Quarter Earnings Results for 20262026-05-08T00:00:00

Previous key dates

NameKey Date
Barclays 28th Annual Global Healthcare Conference2026-03-10T15:30:00
Catalyst Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 20252026-02-26T08:30:00
Catalyst Pharmaceuticals Inc Annual Report for 20252026-02-26T00:00:00
Catalyst Pharmaceuticals Inc Fourth Quarter Earnings Results for 20252026-02-25T00:00:00
44th Annual J.P. Morgan Healthcare Conference2026-01-12T15:45:00
Bank of America CNS Therapeutics Virtual Conference2025-12-08T12:35:00
Citi's 2025 Global Healthcare Conference2025-12-02T13:00:00
Jefferies Global Healthcare Conference Presentation2025-11-17T14:00:00
Catalyst Pharmaceuticals Inc Third Quarter Earnings Conference Call for 20252025-11-06T08:30:00
Catalyst Pharmaceuticals Inc Third Quarter Earnings Results for 20252025-11-05T00:00:00
Baird Global Conference 20252025-09-09T12:50:00
H.C. Wainwright 27th Annual Global Investment Conference 20252025-09-08T09:00:00
Cantor Global Healthcare Conference 20252025-09-04T15:20:00
Wells Fargo Healthcare Conference 20252025-09-03T14:15:00
Catalyst Pharmaceuticals Inc Second Quarter Earnings Conference Call for 20252025-08-07T08:30:00
Catalyst Pharmaceuticals Inc Second Quarter Earnings Results for 20252025-08-06T00:00:00
Catalyst Pharmaceuticals Inc Annual General Meeting for 20242025-05-20T09:00:00
BofA Securities Health Care Conference 20252025-05-14T08:00:00
Catalyst Pharmaceuticals Inc First Quarter Earnings Conference Call for 20252025-05-08T08:30:00
Catalyst Pharmaceuticals Inc First Quarter Earnings Results for 20252025-05-07T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.